Form 4: Roivant Sciences CEO Matthew Gline Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Matthew Gline, CEO of Roivant Sciences, reports the disposal of shares to cover tax obligations related to vested RSUs.
Summary
- On April 20, 2025, Matthew Gline, CEO of Roivant Sciences, disposed of 10,945 common shares to cover tax obligations.
- The shares were sold at a price of $10.15 each.
- Following the transaction, Gline directly owns 17,294,711 common shares of Roivant Sciences.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing related to tax obligations, so it has a neutral sentiment. It doesn't indicate any significant positive or negative developments for the company.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 04/20/2025 | Date of share disposal transaction. |
| 04/22/2025 | Date of signature on the Form 4 filing. |
Keywords
Roivant Sciences, Matthew Gline, Form 4, Share Disposal, RSUs, Tax Obligations, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.